AbbVie Inc. (4AB)
FSX
Closed
Aug 21, 2026
Day's Range
222.7052 wk Range
167.55Overview - 4AB - AbbVie Inc.
Key Statistics
Valuation
Enterprise Value
394.69B
P/E (Trailing)
‪74.63‬
P/E (Forward)
‪16.24‬
PEG Ratio
‪0.26‬
Price / Sales (TTM)
‪6.22‬
Price / Book
‪-68.08‬
EV / EBITDA
‪15.01‬
Profitability
Gross Margin
‪74.74%‬
Profit Margin
‪9.80%‬
Operating Margin
‪40.03%‬
Return on Assets
‪10.51%‬
Return on Equity
‪-129.67%‬
Ownership
Shares Outstanding
1.76B
Float
1.76B
Held by Insiders
‪0.11%‬
Held by Institutions
‪77.43%‬
Price stats
Beta
‪0.28‬
50-Day Avg
‪215.91‬
200-Day Avg
‪194.81‬
Dividends
Payout Ratio
‪190.39%‬
Frequency
Quarterly
Market Cap - 4AB - AbbVie Inc.
Peers - 4AB - AbbVie Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
Profile Summary - 4AB - AbbVie Inc.
About
AbbVie Inc. is a research-based biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative medicines and therapies worldwide. Headquartered in North Chicago, Illinois, and founded in 2012 as a spin-off from Abbott Laboratories, it employs approximately 55,000…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
